as of 07-24-2026 4:00pm EST
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | ALISO VIEJO |
| Market Cap: | 9.0B | IPO Year: | 2015 |
| Target Price: | $126.92 | AVG Volume (30 days): | 692.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.34 | EPS Growth: | -18.41 |
| 52 Week Low/High: | $73.16 - $161.53 | Next Earning Date: | 04-29-2026 |
| Revenue: | $507,442,000 | Revenue Growth: | 32.33% |
| Revenue Growth (this year): | 23.32% | Revenue Growth (next year): | 27.43% |
| P/E Ratio: | -447.44 | Index: | N/A |
| Free Cash Flow: | -22455000.0 | FCF Growth: | N/A |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
SVP & CHIEF FINANCIAL OFFICER
Avg Cost/Share
$160.00
Shares
10,000
Total Value
$1,600,000.00
Owned After
43,906
SEC Form 4
SVP & CHIEF FINANCIAL OFFICER
Avg Cost/Share
$155.00
Shares
10,000
Total Value
$1,550,000.00
Owned After
43,906
SEC Form 4
SVP & CHIEF FINANCIAL OFFICER
Avg Cost/Share
$150.00
Shares
10,000
Total Value
$1,500,000.00
Owned After
43,906
SEC Form 4
CHIEF DEVELOPMENT OFFICER
Avg Cost/Share
$139.06
Shares
716
Total Value
$99,566.96
Owned After
87,634
SEC Form 4
CHIEF DEVELOPMENT OFFICER
Avg Cost/Share
$130.68
Shares
1,537
Total Value
$200,855.16
Owned After
87,634
SEC Form 4
Director
Avg Cost/Share
$135.00
Shares
5,000
Total Value
$675,000.00
Owned After
35,528
SEC Form 4
PRESIDENT & COO
Avg Cost/Share
$143.54
Shares
19,573
Total Value
$2,809,508.42
Owned After
73,419
SEC Form 4
SVP & CHIEF FINANCIAL OFFICER
Avg Cost/Share
$140.00
Shares
10,000
Total Value
$1,400,000.00
Owned After
43,906
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Thurman Alex R. | GKOS | SVP & CHIEF FINANCIAL OFFICER | Jul 16, 2026 | Sell | $160.00 | 10,000 | $1,600,000.00 | 43,906 | |
| Thurman Alex R. | GKOS | SVP & CHIEF FINANCIAL OFFICER | Jul 9, 2026 | Sell | $155.00 | 10,000 | $1,550,000.00 | 43,906 | |
| Thurman Alex R. | GKOS | SVP & CHIEF FINANCIAL OFFICER | Jul 6, 2026 | Sell | $150.00 | 10,000 | $1,500,000.00 | 43,906 | |
| Navratil Tomas | GKOS | CHIEF DEVELOPMENT OFFICER | Jul 1, 2026 | Sell | $139.06 | 716 | $99,566.96 | 87,634 | |
| Navratil Tomas | GKOS | CHIEF DEVELOPMENT OFFICER | Jun 16, 2026 | Sell | $130.68 | 1,537 | $200,855.16 | 87,634 | |
| Kliman Gilbert H | GKOS | Director | May 11, 2026 | Sell | $135.00 | 5,000 | $675,000.00 | 35,528 | |
| Gilliam Joseph E | GKOS | PRESIDENT & COO | May 1, 2026 | Sell | $143.54 | 19,573 | $2,809,508.42 | 73,419 | |
| WEN LEANA | GKOS | Director | May 1, 2026 | Sell | $143.35 | 1,700 | $243,695.00 | 19,739 | |
| Thurman Alex R. | GKOS | SVP & CHIEF FINANCIAL OFFICER | Apr 30, 2026 | Sell | $140.00 | 10,000 | $1,400,000.00 | 43,906 |
SEC 8-K filings with transcript text
Apr 29, 2026 · 100% conf.
1D
+4.39%
$122.10
Act: +22.84%
5D
+11.04%
$129.87
Act: +15.65%
20D
+12.62%
$131.72
Act: -8.93%
SEC.gov | Request Rate Threshold Exceeded
U.S. Securities and Exchange Commission
You’ve Exceeded the SEC’s Traffic Limit
Your request rate has exceeded the SEC’s maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes.
Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains available to all users, we reserve the right to block IP addresses that submit excessive requests.
The block will be lifted automatically by waiting 10 minutes. Continuing to exceed the SEC’s maximum allowable request rate during the time-out period will extend the duration of the time-out period. To ensure fair access for all users, please reduce the rate of your requests and visit SEC.gov again after the 10 minute time-out period has passed.
For best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. You can also sign up for email updates on the SEC open data program, including best practices that make it more efficient to download data, and SEC.gov enhancements that may impact scripted downloading processes. For more information, contact opendata@sec.gov.
For more information, please see the SEC’s Web Site Privacy and Security Policy. Thank you for your interest in the U.S. Securities and Exchange Commission.
Reference ID: 0.e618d017.1784726458.7fb68be
More Information
Internet Security Policy
By using this site, you are agreeing to security monitoring and auditing. For security purposes, and to ensure that the public service remains available to users, this government computer system employs programs to monitor network traffic to identify unauthorized attempts to upload or change information or to otherwise cause damage, including attempts to deny service to users.
Unauthorized attempts to upload information and/or change information on any portion of this site are strictly prohibited and are subject to prosecution under the Computer Fraud and Abuse Act of 1986 and the National Information Infrastructure Protection Act of 1996 (see Title 18 U.S.C. §§ 1001 and 1030).
To ensure our website performs well for all users, the SEC monitors the frequency of requests for SEC.gov content to ensure automated searches do not impact the ability of others to access SEC.gov content. We reserve the right to block IP addresses that submit excessive requests. Current guidelines limit users to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests.
If a user or application submits more than 10 requests per second, further requests from the IP address(es) may be limited for a brief period. Once the rate of requests has dropped below the threshold for 10 minutes, the user may resume accessing content on SEC.gov. This SEC practice is designed to limit excessive automated searches on SEC.gov and is not intended or expected to impact individuals browsing the SEC.gov website.
Note that this policy may change as the SEC manages SEC.gov to ensure that the website performs efficiently and remains available to all users.
Note: We do not offer technical support for developing or debugging scripted downloading processes.
Feb 17, 2026 · 100% conf.
1D
+3.09%
$109.94
Act: +13.47%
5D
+10.93%
$118.30
Act: +11.75%
20D
+14.92%
$122.55
Glaukos Corporation_February 17, 2026 0001192448false00011924482026-02-172026-02-17
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 17, 2026
Glaukos Corporation (Exact name of registrant as specified in its charter)
Delaware 001-37463 33-0945406
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
One Glaukos Way
Aliso Viejo
California 92656
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code: (949) 367-9600 Not Applicable (Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Title of each class: Trading Symbol Name of each exchange on which registered:
Common Stock
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition.
On February 17, 2026, Glaukos Corporation (the “Company”) issued a press release announcing its financial results for the fourth quarter and fiscal year ended December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
The information contained in this Item 2.02 and in the accompanying Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended (the “Securities Act”), except as shall be expressly set forth by specific reference in such filing. Item 7.01. Regulation FD Disclosure.
A Quarterly Summary containing supplemental business and financial information for the Company’s fourth quarter and fiscal year ended December 31, 2025 is furnished as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated by reference herein. A copy of the Quarterly Summary is also available in the “Financials & Filings” section of the Company’s investor relations website at https://investors.glaukos.com. The information contained in this Item 7.01 and in the accompanying Exhibit 99.2 shall not be deemed filed for purposes of Section 18 of the Exchange Act, or incorporated by reference in any filing under the Exchange Act or the Securities Act, except as shall be expressly set forth by specific reference in such filing. Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. Description
99.1
Press Release of Glaukos Corporation, dated February 17, 2026
99.2 Quarterly Summary of Glaukos Corporation for the fourth quarter and fiscal year ended December 31, 2025
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
(Registrant)
By: /s/ Alex R. Thurman
Name: Alex R. Thurman
Title: Senior Vice President & Chief Financial Officer
Date: February 17, 2026
Jan 13, 2026 · 100% conf.
1D
+3.09%
$109.94
Act: +13.47%
5D
+10.93%
$118.30
Act: +11.75%
20D
+14.92%
$122.55
Glaukos Corporation_January 13, 2026 0001192448false00011924482026-01-132026-01-13
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 13, 2026
Glaukos Corporation (Exact name of registrant as specified in its charter)
Delaware 001-37463 33-0945406
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
One Glaukos Way Aliso Viejo, California 92656
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code: (949) 367-9600 Not Applicable (Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Securities registered pursuant to Section 12(b) of the Act:
Title of each class: Trading Symbol Name of each exchange on which registered:
Common Stock
New York Stock Exchange
Item 2.02. Results of Operations and Financial Condition. On January 13, 2026, Glaukos Corporation (the “Company”) issued a press release announcing its preliminary, unaudited net sales results for the fourth quarter and fiscal year ended December 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information contained in this Item 2.02 and in the accompanying Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended (the “Securities Act”), except as shall be expressly set forth by specific reference in such filing. Item 7.01. Regulation FD Disclosure. The Company intends to present the materials attached as Exhibit 99.2 to this Current Report on Form 8-K (the “Investor Presentation”) from time to time in presentations to investors and other stakeholders. The Investor Presentation will also be available on the investor page of the Company’s website at http://investors.glaukos.com. The information contained in this Item 7.01 and in the accompanying Exhibit 99.2 shall not be deemed filed for purposes of Section 18 of the Exchange Act, or incorporated by reference in any filing under the Exchange Act or the Securities Act, except as shall be expressly set forth by specific reference in such filing. Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description
99.1 Press Release of Glaukos Corporation dated January 13, 2026
99.2
Investor Presentation, dated January 2026
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
(Registrant)
By: /s/ Alex R. Thurman
Name: Alex R. Thurman
Title: Senior Vice President & Chief Financial Officer
Date: January 13, 2026
See how GKOS stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "GKOS Glaukos Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.